The B-Raf Status of Tumor Cells May Be a Significant Determinant of Both Antitumor and Anti-Angiogenic Effects of Pazopanib in Xenograft Tumor Models

Brunilde Gril(Center for Cancer Research), Patricia S. Steeg(National Cancer Institute)
PLoS ONE
October 5, 2011
Cited by 19


Related Papers